RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and...

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genetic Arrhythmia Research

Background:

• Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare, inherited arrhythmia.
• Pathogenic RYR2 gene variants cause 60% of CPVT cases.
• Diagnosis often follows life-threatening cardiac events.

Purpose of the Study:

• To compile a comprehensive dataset of RYR2 variants and clinical phenotypes in CPVT patients.
• To analyze the relationship between variant location, age of onset, and treatment efficacy.
• To identify potential for personalized CPVT interventions.

Main Methods:

• Systematic review of publications up to October 2020 (PubMed, Scopus, Embase).
• Cataloging clinical data for RYR2-related CPVT variants.
• Mapping variants to RYR2 structural domains and analyzing clinical data.

Main Results:

• Identified 964 CPVT patients with 263 RYR2 variants from 221 publications.
• Median age of onset for CPVT was 11 years.
• Variants in the core solenoid and channel pore domains were associated with earlier onset.
• Treatment needs varied based on specific RYR2 variants.

Conclusions:

• A comprehensive dataset of CPVT-associated RYR2 variants and phenotypes was compiled.
• Specific RYR2 variant locations (core solenoid, channel pore) correlate with earlier CPVT onset.
• Phenotypic variability suggests a need for personalized treatment strategies for CPVT patients based on their genetic variant.